Clinical Trial Update: Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)

View source ↗

Summary

A prospective observational study in atrial fibrillation patients receiving factor Xa inhibitors evaluates echocardiographic parameters to predict systemic thro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban) (apixaban)
• Xarelto (rivaroxaban) (rivaroxaban)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Atrial Fibrillation (AF) | Status: ACTIVE_NOT_RECRUITING